21 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
15 Apr 24
Regulation FD Disclosure
6:59am
. BHV-1300 demonstrated faster IgG lowering in non-human primates DATAKEY APRIL 2024 ABI CONFERENCE 7
BHV-1300: UNIQUE PROPERTIES MATCHED TO CHRONIC
8-K
EX-99.1
BHVN
Biohaven Ltd.
8 Jan 24
Regulation FD Disclosure
7:30am
and epidemiological data show that interrupting chronic inflammation may slow disease progression ARIA Alzheimer’s Parkinson’s Multiple Sclerosis Other
8-K
EX-99.1
8h1in8
27 Sep 23
Regulation FD Disclosure
6:58am
8-K
EX-99.1
ekbupr7lc5h o1
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm
8-K
EX-99.1
1tily yj2mzpzz7znf
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm
10-Q
63yy4fxn
9 Nov 22
Quarterly report
4:19pm
424B4
62shoy3kn5zocz p6ok
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
baje64wksjidhn4yqvmk
20 Oct 22
IPO registration (amended)
10:00am
S-1
lp656f40sl701s8jje
18 Oct 22
IPO registration
4:03pm
DRS
enxwvhnaz3g9
11 Oct 22
Draft registration statement
12:00am
10-12B/A
EX-99.1
hwe4m4el en
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
1vkhhkf50ew5c1by7ih
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
bfnphx
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
rtf4q2tov uwf
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-99.1
x462c5hb 03om1
10 Aug 22
Registration of securities
5:07pm